Eligible

Nabiximols, the cannabis-based oral spray sold as Sativex, is available for reimbursement as an adjunctive treatment for moderate to severe spasticity in adults with multiple sclerosis (MS) in Ireland who have not responded as expected from other spasticity medications. Marked by muscle stiffness and involuntary spasms or contractions, spasticity is found in approximately 90% of … Read more